These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 26775263)

  • 1. Determinants of multidrug-resistant tuberculosis in Henan province in China: a case control study.
    Zhang C; Wang Y; Shi G; Han W; Zhao H; Zhang H; Xi X
    BMC Public Health; 2016 Jan; 16():42. PubMed ID: 26775263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Previous Smoking Habit and Perceived Social Discrimination with the Risk of Multi-Drug Resistant Tuberculosis in Central Nepal.
    Marahatta SB; Adhikari B; Mishra SR; Raut S; Ramasoota P; Malla P; Kaewkungwal J; Singhasivanon P
    J Nepal Health Res Counc; 2015; 13(29):95-101. PubMed ID: 26411721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the risk factors associated with multidrug-resistant tuberculosis in Sudan: a case-control study.
    Elduma AH; Mansournia MA; Foroushani AR; Ali HMH; Elegail AMA; Elsony A; Holakouie-Naieni K
    Epidemiol Health; 2019; 41():e2019014. PubMed ID: 31010280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for mortality among patients diagnosed with multi-drug resistant tuberculosis in Uganda- a case-control study.
    Kizito E; Musaazi J; Mutesasira K; Twinomugisha F; Namwanje H; Kiyemba T; Freitas Lopez DB; Nicholas NS; Nkolo A; Birabwa E; Dejene S; Zawedde-Muyanja S
    BMC Infect Dis; 2021 Mar; 21(1):292. PubMed ID: 33752637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with primary transmission of multidrug-resistant tuberculosis compared with healthy controls in Henan Province, China.
    Li WB; Zhang YQ; Xing J; Ma ZY; Qu YH; Li XX
    Infect Dis Poverty; 2015; 4():14. PubMed ID: 25806104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of multidrug resistance among previously treated tuberculosis patients in Zimbabwe, 2014.
    Muchena G; Shambira G; Masuka N; Juru T; Gombe N; Takundwa L; Bangure D; Tshimanga M
    Int J Tuberc Lung Dis; 2017 Nov; 21(11):1167-1172. PubMed ID: 29037298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors for multidrug resistance among previously treated patients with tuberculosis in eastern China: a case-control study.
    Chen S; Huai P; Wang X; Zhong J; Wang X; Wang K; Wang L; Jiang S; Li J; Peng Y; Ma W
    Int J Infect Dis; 2013 Dec; 17(12):e1116-20. PubMed ID: 23916547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for diagnosis and treatment delay among patients with multidrug-resistant tuberculosis in Hunan Province, China.
    Akalu TY; Clements ACA; Gebreyohannes EA; Xu Z; Bai L; Alene KA
    BMC Infect Dis; 2024 Feb; 24(1):159. PubMed ID: 38308252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictor of multidrug resistant tuberculosis in southwestern part of Ethiopia: a case control study.
    Gobena D; Ameya G; Haile K; Abreha G; Worku Y; Debela T
    Ann Clin Microbiol Antimicrob; 2018 Jul; 17(1):30. PubMed ID: 29970076
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for multidrug resistant tuberculosis patients in Amhara National Regional State.
    Mulu W; Mekonnen D; Yimer M; Admassu A; Abera B
    Afr Health Sci; 2015 Jun; 15(2):368-77. PubMed ID: 26124781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preventing emergence of drug resistant tuberculosis in Myanmar's transitioning health system.
    Khan MS; Hutchison C; Coker RJ; Yoong J; Hane KM; Innes AL; Khaing TM; Aung S
    Health Policy Plan; 2017 Oct; 32(suppl_2):i43-i50. PubMed ID: 29028228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors for multidrug-resistant tuberculosis among tuberculosis patients in Serbia: a case-control study.
    Stosic M; Vukovic D; Babic D; Antonijevic G; Foley KL; Vujcic I; Grujicic SS
    BMC Public Health; 2018 Sep; 18(1):1114. PubMed ID: 30208864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The long term (9-year) survival of multidrug-resistant tuberculosis patients compared to non-multidrug-resistant tuberculosis patients in Henan province].
    Sun YN; Wang GJ; Zhen XA; Liu ZF; Harley D; Hall G; Vally H; Sleigh A
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Feb; 34(2):133-6. PubMed ID: 23751466
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High treatment failure and default rates for patients with multidrug-resistant tuberculosis in KwaZulu-Natal, South Africa, 2000-2003.
    Brust JC; Gandhi NR; Carrara H; Osburn G; Padayatchi N
    Int J Tuberc Lung Dis; 2010 Apr; 14(4):413-9. PubMed ID: 20202298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportions and Risk Factors of Developing Multidrug Resistance Among Patients with Tuberculosis in China: A Population-Based Case-Control Study.
    Huai P; Huang X; Cheng J; Zhang C; Wang K; Wang X; Yang L; Deng Z; Ma W
    Microb Drug Resist; 2016 Dec; 22(8):717-726. PubMed ID: 27058017
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors contributing to the high prevalence of multidrug-resistant tuberculosis among previously treated patients: a case-control study from China.
    Wang K; Chen S; Wang X; Zhong J; Wang X; Huai P; Wu L; Wang L; Jiang S; Li J; Peng Y; Yao H; Ma W
    Microb Drug Resist; 2014 Aug; 20(4):294-300. PubMed ID: 24328894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing Mycobacterium tuberculosis isolates from Karachi, Pakistan: drug resistance and genotypes.
    Ayaz A; Hasan Z; Jafri S; Inayat R; Mangi R; Channa AA; Malik FR; Ali A; Rafiq Y; Hasan R
    Int J Infect Dis; 2012 Apr; 16(4):e303-9. PubMed ID: 22365136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Key factors influencing multidrug-resistant tuberculosis in patients under anti-tuberculosis treatment in two centres in Burundi: a mixed effect modelling study.
    Iradukunda A; Ndayishimiye GP; Sinarinzi D; Odjidja EN; Ntakaburimvo N; Nshimirimana I; Izere C
    BMC Public Health; 2021 Nov; 21(1):2142. PubMed ID: 34814876
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors contributing to the high prevalence of multidrug-resistant tuberculosis: a study from China.
    Liang L; Wu Q; Gao L; Hao Y; Liu C; Xie Y; Sun H; Yan X; Li F; Li H; Fang H; Ning N; Cui Y; Han L
    Thorax; 2012 Jul; 67(7):632-8. PubMed ID: 22403070
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.